Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinicopathologic Significance of Splenomegally in Adult Patients With Isolated Thrombocytopenia

NCT07182760 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT07182760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07182760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinicopathologic Significance of Splenomegally in Adult Patients With Isolated Thrombocytopenia
Lead sponsor
Assiut University
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2025
Completion date
May 31, 2027
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

amegakaryocytic aplasia, autoimmune diseases with secondary itp, lymphoproliferative disorder with secondary itp, primary immune thrombocytopenic purpura, unilineage myelodysplastic syndrome ( megakaryocyte dysplasia)